Skip to main content
. 2015 Oct 9;241(6):559–568. doi: 10.1177/1535370215609692

Figure 1.

Figure 1

Maximizing the potential efficacy of stem cell therapies will depend on the timing of their use. MSC-derived neuroprotection and neuroretinal cell replacement may help if given early in disease. EPC-derived vascular regeneration may offer benefit right up until end stage disease. Reproduced with permission from Megaw and Dhillon. 23 (A color version of this figure is available in the online journal.)